Biologics/Immunotherapy News

A study found that “significant desensitization” occurred among peanut-allergic toddlers following peanut sublingual immunotherapy, according to data presented at the annual meeting of the American Academy of Allergy, Asthma & Immunology.

Since 1984, the Asthma and Allergy Foundation of America has declared May as National Asthma and Allergy Awareness Month. One common type of allergy is pet allergy, according to the Institute for Quality and Efficiency in Health Care.

In the largest long-term peanut immunotherapy trial to date, the epicutaneous immunotherapy patch known as Viaskin Peanut increased patients’ protection over time from allergic reactions, according to researchers.

Researchers demonstrated that long-term use of sublingual immunotherapy, or SLIT, was an effective and safe option to treat peanut allergy in children aged 1 to 11 years, according to findings published in The Journal of Allergy and Clinical Immunology.

BOSTON — Rheumatologists, gastroenterologists, dermatologists, immunologists and other health care providers who care for patients with immune-mediated inflammatory diseases will gather at the Interdisciplinary Autoimmune Summit in Boston this weekend for a collaborative discussion of treatment strategies.

NEW ORLEANS — About 95% of patients currently labeled as penicillin allergic are not and most can be de-labeled through skin tests, John M. Kelso, MD, from the division of allergy, asthma and immunology at Scripps Clinic, told Healio Internal Medicine.

Healio.com/Allergy will present live coverage of the 75th American Academy of Allergy, Asthma and Immunology annual meeting from Boston beginning Oct. 26 through Oct. 30.

ATLANTA — Lower and high doses of wheat oral immunotherapy induced significant desensitization in most wheat-allergic children following 1 year of treatment, according to data presented at the annual meeting of the American Academy of Allergy, Asthma & Immunology.

ATLANTA — Walnut oral immunotherapy effectively induced walnut desensitization, as well as cross-desensitization to a secondary tree nut, in a majority of tree nut-allergic patients, according to early data presented at the annual meeting of the American Academy of Allergy, Asthma & Immunology.

A majority of patients in this study who underwent allergen immunotherapy for house dust mites showed house dust mite-allergic rhinitis-associated conjunctivitis, with more than 40% of patients showing uncontrolled asthma despite prescription medication prior to therapy, according to a recent study.